Firearm Marksmanship and Adolescent Lead Exposure: Adverse Health Effects, Surveillance, Control, and Prevention

The goal of this course is to enhance the knowledge of physicians and other healthcare providers about the health impacts of lead exposure at firing ranges and competitive marksmanship among adolescent populations. By enhancing their knowledge, physicians and other healthcare providers can better assess adolescent patients who may suffer symptoms caused by lead exposure, provide informed guidance to their patients and their caregivers, and advocate for measures to control lead exposure in firing range environments.

Learning Objectives

When you complete this module, you will be able to:

• Describe three measures to control lead exposure in firing range environments
• Describe two appropriate primary prevention and surveillance measures for youth actively engaging in marksmanship
• Discuss two recommendations for medical surveillance of adolescents exposed to lead and action plans to reduce lead exposure.

Presented By

Rose Goldman, MD, MPH
Director of Faculty Affairs, Dept. of  Medicine, Cambridge Health Alliance Associate Professor of Medicine, Harvard Medical School Associate Professor of Environmental Health Sciences, Harvard T.H. Chan School of Public Health

Alan Woolf, MD, MPH, FAAP, FAACT, FACMT
Associate Chief Medical Education Officer, Boston Children's Hospital
Director, Region 1 PEHSU

Original Date: October 1, 2018
Renewal Date: October 1, 2020
Expiration Date: October 2, 2022

Accreditation Statements

In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention and Pediatric Environmental Health Specialty Unit (PEHSU). The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team

CME:  The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE:  The Centers for Disease Control and Prevention designates this activity for 1.3 nursing contact hours.

CEU:  The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES^®) and/or Master

Certified Health Education Specialists (MCHES^®) to receive up to 1.5 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. Continuing Competency credits available are 1.5. CDC provider number 98614.

For Certified Public Health Professionals (CPH)

The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 2.0 CPH recertification credits for this program.

DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.

CDC, our planners, content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.

Planning committee reviewed content to ensure there is no bias.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept commercial support for this continuing education activity.

WB4107